Moving the Goal Posts. Definitions of Success after Glaucoma Surgery and Their Effect on Reported Outcome

Ophthalmology

Volumn 117, Issue 1, 2010, Pages

  Rotchford, Alan P ^a   King, Anthony J ^b  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ARTICLE; CLINICAL TRIAL; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; INTRAOCULAR PRESSURE; MEDICAL LITERATURE; OCULOPLETHYSMOGRAPHY; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TRABECULECTOMY; VISCOCANALOSTOMY;

EID: 72749121995     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.06.014     Document Type: Article

References (14)

1. Chauhan B.C., Garway-Heath D.F., Goni F.J., et al. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol 92 (2008) 569-573
2. Kass M.A., Heuer D.K., Higginbotham E.J., et al., Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 701-713 discussion 829-30
3. Leske M.C., Heijl A., Hussein M., et al., Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol 121 (2003) 48-56
4. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 126 (1998) 498-505
5. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130 (2000) 429-440
6. Jampel H.D. Target pressure in glaucoma therapy. J Glaucoma 6 (1997) 133-138
7. Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol 121 (1996) 349-366
8. Gedde S.J., Schiffman J.C., Feuer W.J., et al., Tube Versus Trabeculectomy Study Group. Treatment outcomes in the Tube versus Trabeculectomy Study after one year of follow-up. Am J Ophthalmol 143 (2007) 9-22
9. CAT-152 0102 Trabeculectomy Study Group. A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. Ophthalmology 114 (2007) 1822-1830
10. Edmunds B., Thompson J.R., Salmon J.F., and Wormald R.P. The National Survey of Trabeculectomy: II. Variations in operative technique and outcome. Eye 15 (2001) 441-448
11. O'Brart D.P., Shiew M., and Edmunds B. A randomised, prospective study comparing trabeculectomy with viscocanalostomy with adjunctive antimetabolite usage for the management of open angle glaucoma uncontrolled by medical therapy. Br J Ophthalmol 88 (2004) 1012-1017
12. Skuta G.L., Beeson C.C., Higginbotham E.J., et al. Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology 99 (1992) 438-444
13. Begg C., Cho M., Eastwood S., et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 276 (1996) 637-639
14. Mills E.J., Wu P., Gagnier J., and Devereaux P.J. The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. Contemp Clin Trials 26 (2005) 480-487